Yayın:
Exploring the Modulatory Effects of Vitamin B12 on Morphine-Induced Conditioned Place Preference in Rats

dc.contributor.authorUskur, Tugce
dc.contributor.authorTasdemir, Fatma Unlu
dc.contributor.authorOzturk, Mehmetaykut
dc.contributor.authorSonmez, Haktan
dc.contributor.authorSeven, Zeynep Gizem Todurga
dc.contributor.authorGokdemir, Selim
dc.contributor.authorBastan, Burak
dc.contributor.authorFaikoglu, Gokhan
dc.contributor.authorFaikoglu, Kuebra Saygisever
dc.contributor.authorOzyazgan, Sibel
dc.contributor.authorYillar, Duendar Okan
dc.contributor.authorAkkan, Ahmet Gokhan
dc.date.accessioned2026-06-27T15:21:39Z
dc.date.issued2025
dc.description.abstractBackground: This study aims to investigate the effects of vitamin B12 on morphine-induced conditioned place preference (CPP), a model commonly used to assess the rewarding effects of drugs. Morphine is a potent analgesic widely used for moderate to severe pain, but it also poses a significant risk of addiction. Previous studies suggest that cyanocobalamin (vitamin B12) may enhance the analgesic effects of morphine and reduce tolerance, but its impact on morphine addiction remains unclear. Methods: The experiment followed phases of habituation, pre-conditioning, conditioning, and post-conditioning. Adult male Wistar albino rats (250-300 g) were randomly divided into 3 groups (n = 8 per group): control (saline), morphine (10 mg/kg), and a combination group of vitamin B12 (2 mg/kg) with morphine. The effects of saline, morphine, and the morphine-vitamin B12 combination on CPP were assessed. All drugs and saline were administered intraperitoneally (ip). Results: Morphine (10 mg/kg) significantly induced CPP compared to the saline group (P < .0001). Vitamin B12 (2 mg/kg) did not produce a statistically significant difference in morphine-induced CPP compared to the control group. Conclusion: Morphine induces a significant place preference, and vitamin B12 did not produce a statistically significant difference in reducing this effect. Further research with different doses of vitamin B12 is necessary to fully investigate these effects.en
dc.description.urihttps://doi.org/10.5152/pcp.2025.241005
dc.identifier.doi10.5152/pcp.2025.241005
dc.identifier.eissn2475-0581
dc.identifier.endpage274
dc.identifier.issn2475-0573
dc.identifier.issue3
dc.identifier.pubmed40824234
dc.identifier.startpage269
dc.identifier.urihttps://hdl.handle.net/20.500.14981/70181
dc.identifier.volume35
dc.identifier.wos001548315400009
dc.language.isoeng
dc.publisherAVES
dc.relation.ispartofPSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY
dc.rightsopenAccess
dc.subjectCYANOCOBALAMIN VITAMIN-B12
dc.subjectTOLERANCE
dc.subjectINVOLVEMENT
dc.subjectDEPENDENCE
dc.subjectEXPRESSION
dc.subjectPAIN
dc.subjectPharmacology & Pharmacy
dc.subjectPsychiatry
dc.titleExploring the Modulatory Effects of Vitamin B12 on Morphine-Induced Conditioned Place Preference in Rats
dc.typeArticle
dspace.entity.typePublication
local.import.sourceWOS

Dosyalar

Koleksiyonlar